Mexoryl XL is an exclusive sun filtering system developed by the La Roche-Posay Laboratory for its Anthélios XL suncare range. Touted by dermatologists and sun care afficiandos alike, those in the know, know that sunscreens with Mexoryl XL deliver!
Mexoryl XL, when combined with other chemical sun filters such as, titanium dioxide, Parsol 1789 (avobenzone, and octocrylene, produces a strong barrier against the damaging UVA rays. La Roche Posay produces two Mexoryl molecules, Mexoryl XL and Mexoryl SX. Mexoryl SX is water soluble and recommended for daily wear. Mexoryl XL is oil soluble, so it’s ideal for using when you are going to be outside for extended periods of time.
Mexoryl XL also has the characteristic of staying on your skin for longer periods of time while maintaining its efficacy. In addition, research has shown that Mexoryl XL is slightly better than Mexoryl SX at filtering the UVA rays. When both Mexoryl molecules are combined, they provide complete protection against both UVB and UVA rays. These are powerful facts to consider since most sunscreens available right now only protect against UVB rays, so their protection is only partial.
Mexoryl XL’s photostable UVA protection has proved its worth. To date, 17 clinical trials have shown how well it performs in the fight against damage caused or aggravated by UV rays. These trials have been published in numerous international scientific journals.
Mexoryl XL may be found in Anthelios and Ombrelle sunscreens and may be purchased at quality pharmacies throughout Canada and worldwide.
Now a new study has emerged, confirming Anthélios XL’s power to protect cells. It has been demonstrated that Mexoryl XL protects the epidermis (the top layer of the skin) and in particular Langerhans cells (cells partly responsible for the skin’s immunity) against the sun’s rays. Application of Anthélios XL to the skin of healthy volunteers, prior to UV exposure blocked UV-induced immuno-suppression. This feature has big implications in the protection against some types of skin cancers.